Kettle Hill Capital Management LLC acquired a new stake in Rxo Inc (NYSE:RXO – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 136,015 shares of the company’s stock, valued at approximately $1,719,000.
Several other institutional investors have also modified their holdings of RXO. Royal Bank of Canada lifted its holdings in shares of RXO by 14.3% in the first quarter. Royal Bank of Canada now owns 23,251 shares of the company’s stock valued at $444,000 after buying an additional 2,902 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in RXO by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 94,940 shares of the company’s stock valued at $1,813,000 after buying an additional 4,134 shares during the period. Geneos Wealth Management Inc. acquired a new position in RXO during the first quarter valued at $30,000. Strs Ohio acquired a new position in RXO during the first quarter valued at $97,000. Finally, Quantbot Technologies LP acquired a new position in RXO in the 2nd quarter worth about $245,000. Institutional investors and hedge funds own 92.73% of the company’s stock.
RXO Price Performance
Shares of NYSE:RXO opened at $27.53 on Tuesday. The business has a 50 day moving average price of $21.57 and a 200 day moving average price of $16.92. Rxo Inc has a twelve month low of $10.43 and a twelve month high of $29.86. The company has a market cap of $4.54 billion, a price-to-earnings ratio of -45.14, a PEG ratio of 30.10 and a beta of 2.08. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.28.
Wall Street Analysts Forecast Growth
RXO has been the topic of several research reports. Barclays upped their target price on RXO from $17.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Zacks Research upgraded RXO from a “strong sell” rating to a “hold” rating in a research note on Monday, April 6th. TD Cowen upped their price target on RXO from $14.00 to $21.00 and gave the stock a “hold” rating in a research note on Friday, May 8th. Weiss Ratings upgraded RXO from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. Finally, Wall Street Zen upgraded RXO from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $20.08.
Read Our Latest Stock Analysis on RXO
RXO Company Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
See Also
- Five stocks we like better than RXO
- This Golden Cross Could Send Urban Outfitters to New Highs
- Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold?
- Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
